Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
Phase 1/2 Terminated
53 enrolled 22 charts
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
Phase 2 Terminated
90 enrolled 24 charts
ABT-888 and Temozolomide for Liver Cancer
Phase 2 Terminated
16 enrolled 11 charts
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Phase 1/2 Terminated
74 enrolled 23 charts
Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors
Phase 1 Terminated
12 enrolled 13 charts
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
Phase 2 Terminated
15 enrolled 9 charts
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
Phase 1/2 Terminated
14 enrolled 11 charts
I-ATTAC
Phase 2 Terminated
6 enrolled 7 charts
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
Phase 1 Terminated
7 enrolled 12 charts
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Terminated
4 enrolled 6 charts
T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Phase 1/2 Terminated
12 enrolled 16 charts
VITA
Phase 3 Terminated
32 enrolled 13 charts
Study of Temzolomide and Gleevec in Advanced Melanoma
Phase 1/2 Terminated
32 enrolled 8 charts
GCC 1224
Phase 2 Terminated
24 enrolled 9 charts
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Phase 2 Terminated
27 enrolled 15 charts
329
Phase 1/2 Terminated
12 enrolled 13 charts
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Phase 2 Terminated
13 enrolled 23 charts
PERFORMANCE
Phase 1 Terminated
27 enrolled 13 charts
PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Phase 3 Terminated
20 enrolled 13 charts
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Phase 1/2 Terminated
21 enrolled 8 charts
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
Phase 2 Terminated
1 enrolled 8 charts
Biochemotherapy With Temozolomide for Metastatic Melanoma
Phase 2 Terminated
5 enrolled 5 charts
Doxycycline, Temozolomide and Ipilimumab in Melanoma
Phase 1/2 Terminated
12 enrolled 6 charts
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
Phase NA Terminated
15 enrolled 6 charts
Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas
Phase 2 Terminated
54 enrolled 10 charts
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
Phase 2 Terminated
53 enrolled 12 charts
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
Phase 3 Terminated
27 enrolled 1 chart
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
Phase 2 Terminated
41 enrolled 9 charts
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Phase 1/2 Terminated
12 enrolled 12 charts
A Safety Study in Participants With Advanced Solid Tumors
Phase 1 Terminated
234 enrolled 23 charts
DRBEAT
Phase 2 Terminated
11 enrolled 10 charts
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
Phase 2 Terminated
16 enrolled 6 charts
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Phase 1 Terminated
4 enrolled 8 charts
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
Phase 3 Terminated
126 enrolled 14 charts
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
Phase 2 Terminated
3 enrolled 7 charts
Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Phase 1/2 Terminated
39 enrolled 8 charts
STOP
Phase 2 Terminated
6 enrolled 9 charts
Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)
Phase 2 Terminated
35 enrolled 7 charts
Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)
Phase 2 Terminated
53 enrolled 10 charts
STRONG
Phase NA Terminated
4 enrolled 8 charts
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
Phase 2 Terminated
12 enrolled 10 charts
Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma
Phase 2 Terminated
2 enrolled 6 charts
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
Phase 2 Terminated
1 enrolled 3 charts
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Phase 2 Terminated
28 enrolled 9 charts
Pilot Trial of "Chemo-Switch" Regimen to Treat Advanced Melanoma
Phase 2 Terminated
9 enrolled 3 charts
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
Phase 2 Terminated
3 enrolled 3 charts